Hot topics close

Eli Lilly commits $5.3B to more Zepbound, Mounjaro production

Eli Lilly commits 53B to more Zepbound Mounjaro production
Boosting production and creating jobs, Eli Lilly invests $5.3 billion in Indiana plants for Zepbound and Mounjaro, with potential label expansion for Zepbound.

Two Eli Lilly manufacturing plants in Indiana are getting a $5.3 billion boost to increase production of Zepbound and Mounjaro, the company said May 24. 

The investment "represents the single largest investment in synthetic medicine [active pharmaceutical ingredient] manufacturing in U.S. history," Eli Lilly's chair and CEO David Ricks said in a news release. 

Leaders of the manufacturing sites in Lebanon, Ind., will hire 200 full-time workers to help increase production. Mounjaro is approved for Type 2 diabetes and Zepbound is indicated for chronic weight management. Eli Lilly is also eyeing a Zepbound label expansion after finding positive results in a sleep apnea trial. 

The announcement raises the company's total investment in the Lebanon site from $3.7 billion to $9 billion. 

Similar shots
News Archive
  • England vs Nigeria
    England vs Nigeria
    England show resilience of World Cup favourites vs. Nigeria ESPN
    7 Aug 2023
    3
  • Ismael Barroso
    Ismael Barroso
    The 5 Best Opponents for Rolly Romero After Win vs. Ismael Barroso
    14 May 2023
    2
  • Governor Murphy
    Governor Murphy
    Murphy orders N.J. residents to stay home, closes non-essential retail businesses in state lockdown to fight
    21 Mar 2020
    3
  • Open Championship
    Open Championship
    The Open round review: Justin Thomas holds clubhouse lead at ...
    18 Jul 2024
    2
  • Louise Fletcher
    Louise Fletcher
    Louise Fletcher, 88, Dies; Oscar Winner for ‘One Flew Over the Cuckoo’s Nest’
    24 Sep 2022
    1
  • Gregg Berhalter
    Gregg Berhalter
    USA coach Gregg Berhalter fired after Copa América failure ESPN
    11 Jul 2024
    4
This week's most popular shots